Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit
Law 360
MARCH 29, 2024
A New York federal judge has granted a win to hedge fund Armistice Capital LLC and its managing member in a derivative suit brought by a shareholder of biotechnology company Vaxart Inc., which sought disgorgement of short-swing profits that allegedly were wrongfully obtained by the investment adviser.
Let's personalize your content